Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 4Crohn Disease 3Lymphoma, Follicular 1Adenocarcinoma of Lung 1

Interventions

Adalimumab 13Etanercept 8Methotrexate 7Rituximab 6Abatacept 6tocilizumab 5golimumab 5tofacitinib 4olokizumab 4Certolizumab Pegol 4Tumor Necrosis Factor Inhibitors 3Infliximab 3Saline Solution 2Antirheumatic Agents 2upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1baricitinib 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1Sulfasalazine 1Sodium Chloride 1Radioimmunodetection 1RC-18 1Pharmaceutical Preparations 1Lysine Acetyltransferase 5 1Leflunomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all
NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

NCT02778789 2019-09-26

Re-Bone

University of Erlangen-Nürnberg Medical School

Completed
66 enrolled

Arthritis, Rheumatoid

NCT01295151 2016-11-02

SWITCH

University of Leeds

Phase 4 Completed
122 enrolled

Arthritis, Rheumatoid

NCT01374971 2014-04-08

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

Arthritis Treatment Center, Maryland

Phase 3 Completed
12 enrolled 4 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡